Recent Advances in Innovative Magnetic Nanomaterials for Cancer Theranostics
- Sudip Mukherjee
- October 2019
Description
This book provides a detailed overview of cancer theranostics applications of magnetic iron oxide nanoparticles. Their synthesis, characterization, multifunctionality, disease targeting, biodistribution, pharmacokinetics and toxicity are highlighted, along with current examples of clinical trials of magnetic nanoparticles in cancer theranostics, and their future scopes and challenges.
About Editors
Sudip Mukherjee is a postdoctoral research associate at the department of bioengineering at Rice University. His research involves in the development of advanced nano/bio materials for drug delivery in cancer theranostics, immunomodulatory applications in cancer and diabetes, and angiogenesis. He has published more than 36 peer-reviewed research articles, three book chapters and three patents. He serves as an international advisory board member of Materials Research Express journal and also works as a scientific blog writer for RSC's Biomaterials Science.
Table of Contents
Table of Contents
Chapter 1: Introduction
1.1. Cancer and statistics
1.2. Conventional therapies for cancer and their limitations
1.3. Alternative theranostics strategy: Nanomedicine
1.4. Magnetic nanoparticles and cancer theranostics
Chapter 2: Magnetic nanoparticles: Types, synthesis and characterization
2.1 Common types of magnetic nanomaterials and their synthesis
2.2 Characterization techniques
2.3 Multilayer concept
Chapter 3: Magnetic nanoparticles for cancer diagnostics
3.1. MRI
3.2. Multimodal imaging
3.3. Biosensors
3.4. Cell labeling
Chapter 4: Magnetic nanoparticles for cancer therapeutics
4.1. Drug delivery: Chemotherapeutics, Biotherapeutics and Radiotherapeutics
4.2. Magnetic Hyperthermia
4.3. Photodynamic therapy
4.4. Photothermal ablation
4.5. MNPs as Anticancer agent
4.6. MNPs in Cancer Immunotherapy
Chapter 5: Safety of Magnetic nanomaterials, Challenges, future scope and Conclusion
5.1. Pharmacokinetics, biodistribution, toxicity
5.2. Targeting
5.3. Magnetic nanoparticles as FDA approved or in clinical trials
5.4. Challenges, future scopes and conclusion
Bibliographic
Paperback ISBN: 9780750330206
Ebook ISBN: 9781643277851
DOI: 10.1088/2053-2571/ab41ef
Publisher: Morgan & Claypool Publishers